Clinical trial
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical…
NCT00075569 · Albert Einstein College of Medicine, Other · Completed
Key facts
| NCT number | NCT00075569 |
|---|---|
| Title | SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia |
| Official title | SGN-00101 (HspE7) Immunotherapy Of CIN III |
| Lead sponsor | Albert Einstein College of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Precancerous Condition |
| Intervention type | Biological |
| Interventions | HspE7 |
| Enrollment | 64 |
| Start date | Mar 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jan 12, 2004 |
| Last update posted | May 21, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: